RecruitingNot ApplicableNCT06419244

Myosteatosis in Oeso-gastric Cancer: Clinical Impacts


Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Enrollment

50 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this project is to study the presence of cancer-associated adipocytes in oesogastric cancers and their possible links with myosteatosis. This research project has a retrospective component, the aim of which is to analyse the body component based on imaging in patients with oesogastric neoplasia in order to determine the incidence of myosteatosis and to study the relationship with oncological and prognostic data. The second part of the project is prospective and will collect biological material (skeletal muscle, adipose tissue, tumour, blood) for histological, molecular and genomic analyses and will analyse muscle function in patients with oesogastric cancer. It will address the role of adipocytes in the tumour microenvironment of oesogastric cancer, focusing on their interactions with the observed muscle myosteatosis and prognosis. In the future, it will help to identify signalling pathways, targets and patients who could benefit from appropriate treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients with cancer of the oesophagus, oeso-gastric junction or stomach
  • Treatment and estimated survival of more than 3 months
  • Signed informed consent
  • \> 18 years of age

Exclusion Criteria4

  • Neuromuscular or orthopedic pathology
  • Cognitive disorders
  • Psychiatric disorders
  • Inability to communicate in French or English

Interventions

DIAGNOSTIC_TESTMyosteatosis

Determination of myosteatosis by imaging


Locations(1)

Cliniques universitaires Saint-Luc

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06419244


Related Trials